Feel Therapeutics develops biomarkers and digital therapeutics to change the way mental health is diagnosed, managed, and cared for. The company develops wristbands with integrated sensors that measure a variety of bio-signals. The connected mobile app provides personalized recommendations and coaching to help users improve emotional well-being, as well as physiological and digital biomarkers and metrics. The company is a direct-to-consumer firm that is aimed at patients with Major Depressive Disorder and/or Generalized Anxiety Disorder. The company primarily partners with pharmaceutical companies, to advance their clinical development, RWE, and commercialization strategies. It was formerly known as Myfeel and Sentio Solutions. It was founded in 2015 and is based in San Francisco, Californ

EndeavorRx is an ADHD treatment for kids aged 8-12. It’s delivered through an immersive video game experience on mobile devices. Created by world-class neuroscientists and award-winning game designers, it targets areas of the brain that play a key role in attention function. As an FDA-authorized medical device, EndeavorRx must be prescribed by a healthcare professional. It should be considered for use as part of a therapeutic program.

Objective measurement tools have been utilized in almost every medical field for centuries. But, when it comes to Mental Health, we still rely on episodic and subjective based self-reported questionnaires to track symptoms and offer episodic care, leading to suboptimal and delayed intervention. We are a Digital Precision Medicine company with the objective to reinvent the way we diagnose, manage and care for Mental Health by bringing objective data and passive measurement into the field.

It's time to change the way medicine is designed, delivered and experienced. At Akili, we believe effective medicine for serious illnesses can also be fun and engaging. We're creating a new class of digital medicines for people living with cognitive impairment, delivered through captivating video game experiences.